An interventional study of Neural Mobilization with Intermittent Cervical Traction and Neural Mobilization in Cervical Radiculopathy, sponsored by University of Lahore. Recruiting at 1 site in Pakistan. Open to participants aged 35 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by University of Lahore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Radiculopathy with a site in Pakistan — 20 open to participants now, 27 under way, none of them phase 3. Radiculopathy · Pakistan.
Among the 72 studies in Radiculopathy with a site in Pakistan, this one is the 4th largest by planned enrollment of the 71 interventional ones that give a count, is one of 17 that started in 2023, is one of 71 with no phase, reaches primary completion later than 4 of the 26 other live ones, and was the 33rd registered.
488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.
Browse Radiculopathy studies →20 of the 72 studies in Radiculopathy with a site in Pakistan are open now. Recruiting first, the newest first:
Foundation University Islamabad · Sites in Pakistan
Ages 30–50
Ibadat International University, Islamabad · Sites in Pakistan
Ages 25–55
Riphah International University · Sites in Pakistan
Ages 20–40
Khyber Medical University Peshawar · Sites in Pakistan
Ages 20–50
Riphah International University · Sites in Pakistan
Ages 30–50
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.
This study: 35 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 17 started in 2023.
This study's planned enrollment of 85 is above the median of 60 across 375 interventional studies indexed under Radiculopathy.
Median enrollment 44 across the 71 interventional studies, 100 across the 1 observational. Of the 41 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 72 have an industry lead sponsor. The 10 most frequent:
University of Lahore is the lead sponsor of 237 studies on the registry; 47 are open to participants now.
University of Lahore has 6 studies filed under Radiculopathy — fewer than ten, so there is no comparison to draw.
2 of the studies in Radiculopathy with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07912073University of Management and Technology LahoreComparative Effects of Kinetic Control Training and Neural Mobilization in Lumbar Radiculopathy | 2026-12-31 |
| NCT07887685Foundation University IslamabadComparative Effect Between Mulligan Leg Raise and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy | 2027-01-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 72 studies in Radiculopathy with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cervical radiculopathy commonly called "pinched nerve," occurs when a nerve in the neck is compressed or irritated where it branches away from the spinal cord. This may cause pain that radiates into the shoulder and/or arm, as well as muscle weakness and numbness.
Cervical radiculopathy (CR) is a disorder of the peripheral nervous system that affects the normal function of the cervical nerve roots (CNRs). It is frequently linked to chronic pain and daily functional limitations. The goal of the neural tissue mobilization technique is to restore the nervous system's capacity to tolerate the normal compressive, tensile, and frictional forces that are associated with day-to-day activities and to examine the neural tension in nerves and mobilize the nerves that exhibit neural tension through passive and active movements using tensioning and gliding. Cervical traction reduces pressure within the vertebral disks and unloads the structures of the spine by stretching muscles and ligaments. They are clinically important techniques that are easily understood by patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in this experimental group will receive neural mobilization with intermittent cervical traction and routine physical therapy.
Other: Neural Mobilization with Intermittent Cervical Traction
Patients in this control group will receive neural mobilization and routine physical therapy.
Other: Neural Mobilization
This group will receive Neural Mobilization with Intermittent Cervical Traction along with routine physical therapy. The patient will be positioned in a supine position with 10 to 15 degrees of flexion on a comfortable treatment table. A suitable pillow will be arranged to support their head. The cervical traction device's integrity and readiness will be confirmed by the therapist. The starting weight will be about 10% of the patient's body weight, and this will slowly increase up to an appropriate level. The on-and-off times will be decided based on the patient's comfort and specific condition. Generally, a ratio of 3:1 or 4:1 (hold: rest) is used. For instance, 60 seconds of traction followed by 20 seconds of rest. The total treatment time will generally range between 15-20 minutes for 3 to 4 times per week. Participants will be scheduled to attend 12 treatment sessions ( 3-4 sessions every week for 4 weeks; 45 min each session).
This Group will receive Neural Mobilization with routine physical therapy. Each nerve glide exercise will be performed ideally around 2-3 times, depending on the patient's comfort and tolerance levels. The intensity of the exercise is governed by the degree of stretch applied to the nerve. This should be within the patient's comfort level, causing a mild stretching sensation rather than pain. Each nerve glide will be performed in a set of 10-15 repetitions. Rest periods should be provided between each repetition and set, ensuring the patient's comfort. In median nerve glide the patient will be seated comfortably. Their arm will be guided into shoulder depression, elbow extension, forearm supination, and wrist and finger extension. The patient will then be instructed to slowly flex and extend their wrist while maintaining the other positions. Participants will be scheduled to attend 12 treatment sessions ( 3-4 sessions every week for 4 weeks; 45 min each session).
Pain Intensity
Pain intensity is assessed using the Visual Analogue Scale (VAS), a unidimensional measure of pain intensity. The scale ranges from 0 (no pain) to 10 (worst possible pain), with the patient asked to rate their current level of pain.
Time frame: Pain intensity will be measured at baseline, and change in pain intensity will be measured at 2nd week and 4th week of treatment session.
Status of Sleep Quality
Sleep quality is evaluated using the Chronic Pain Sleep Inventory (CPSI), a self- administered, a multidimensional questionnaire that assesses sleep disturbances related to chronic pain. Patients report their sleep-related difficulties on a scale of 0 to 100, where 0 represents never having sleep disturbances and 100 represents always having sleep disturbances.
Time frame: Sleep quality will be measured at baseline, and change in sleep quality status will be measured at 2nd week and 4th week of treatment session.
Change in Quality of Life
Quality of Life (QOL) is assessed using the SF-36 questionnaire, a standard, validated instrument for measuring health-related quality of life. The SF-36 covers eight health domains: physical function, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Its score ranges from 0 to 100 with 0 representing poor quality of life and 100 representing good quality of life.
Time frame: Quality of life will be measured at baseline, and change in quality of life will be measured at 2nd week and 4th week of treatment session.
Change in Grip Strength
Grip strength is evaluated using an isometric dynamometer, a device designed to assess the maximum isometric strength of the hand and forearm muscles. Grip strength for males range from 40 to 64 kg and for females from 20 to 38 kg
Time frame: Grip Strength will be measured at baseline, and change in grip strength will be measured at 2nd week and 4th week of treatment session.
Plan to share: Yes
Supporting information: Study protocol
Time frame: After publication of manuscript.
No publications or documents are linked to this record.
Started Sep 2023 (actual). Primary completion is estimated for Dec 2023, 3 months after the start.
Of 205 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's planned 3 months is below that.
Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 5 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.